Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, vaccines, advanced therapies, and oncolytic viruses, announced the completion of an expansion of its cell-therapy manufacturing facility in Thousand Oaks, California. The event also celebrated the recent European Medicines Agency (EMA) site issuance of a Certificate of GMP Compliance of a Manufacturer. This [...] The post Fujifilm Diosynth Biotechnologies completes expansion at manufacturing site in California appeared first on Chemical Engineering.
Fujifilm Diosynth Biotechnologies is a North Carolina-based CDMO that provides services such as cell line development and microbial fermentation for the pharmaceutical sector.